We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Amgen
AMGN
$212B
| $4.78M | 0.04% |
+25,924
| New | +$4.64M |
|
502
Berkshire Hathaway Class B
BRK.B
$1.11T
| $4.77M | 0.04% |
+22,379
| New | +$4.63M |
|
503
J.M. Smucker
SJM
$13.2B
| $4.77M | 0.04% |
41,414
+32,799
| +381% | +$4M |
|
504
PUT
Invesco QQQ Trust
QQQ
$445B
| $4.76M | 0.04% |
25,300
+23,600
| +1,388% | +$4.34M |
|
|
MDSO
505
DELISTED
Medidata Solutions, Inc.
MDSO
| $4.76M | 0.04% |
52,654
+44,036
| +511% | +$3.86M |
|
|
SIVB
506
DELISTED
SVB Financial Group
SIVB
| $4.76M | 0.04% |
21,201
+20,870
| +6,305% | +$4.83M |
|
|
GRP.U
507
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $4.75M | 0.04% |
102,943
-95,970
| -48% | -$4.42M |
|
508
Bank of N.T. Butterfield & Son
NTB
$2.37B
| $4.75M | 0.04% |
139,831
-54,656
| -28% | -$2.02M |
|
509
Plains All American Pipeline
PAA
$17.2B
| $4.75M | 0.04% |
194,965
-141,447
| -42% | -$3.38M |
|
510
Hackett Group
HCKT
$266M
| $4.72M | 0.04% |
+280,933
| New | +$4.53M |
|
|
WMGI
511
DELISTED
Wright Medical Group Inc
WMGI
| $4.69M | 0.04% |
+157,315
| New | +$4.8M |
|
512
iShares MSCI China ETF
MCHI
$6.16B
| $4.68M | 0.04% |
+78,747
| New | +$4.73M |
|
513
FirstCash
FCFS
$9.06B
| $4.67M | 0.04% |
+46,693
| New | +$4.44M |
|
|
AVX
514
DELISTED
AVX Corporation
AVX
| $4.64M | 0.04% |
279,893
+229,076
| +451% | +$3.77M |
|
515
Compass Minerals
CMP
$1.25B
| $4.59M | 0.04% |
+83,582
| New | +$4.62M |
|
516
Moog Inc Class A
MOG.A
$13.1B
| $4.59M | 0.04% |
+49,026
| New | +$4.37M |
|
|
GB
517
DELISTED
Global Blue Group Holding
GB
| $4.59M | 0.04% |
450,000
| – | – |
|
|
SWI
518
DELISTED
SolarWinds Corporation Common Stock
SWI
| $4.58M | 0.04% |
+236,508
| New | +$4.65M |
|
519
Noodles & Co
NDLS
$88.2M
| $4.53M | 0.04% |
71,905
+8,970
| +14% | +$518K |
|
520
ICU Medical
ICUI
$4.14B
| $4.52M | 0.04% |
17,945
+3,438
| +24% | +$797K |
|
|
BMTX
521
DELISTED
BM Technologies, Inc.
BMTX
| $4.52M | 0.04% |
450,000
| – | – |
|
522
Spyre Therapeutics
SYRE
$8.68B
| $4.51M | 0.04% |
26,348
+11,312
| +75% | +$1.96M |
|
|
AUY
523
DELISTED
Yamana Gold, Inc.
AUY
| $4.51M | 0.04% |
1,788,404
+1,544,948
| +635% | +$3.4M |
|
|
MTSC
524
DELISTED
MTS Systems Corp
MTSC
| $4.48M | 0.04% |
+76,593
| New | +$4.26M |
|
525
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $4.42M | 0.04% |
40,558
-22,270
| -35% | -$2.57M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.